SCHEMBL8311361

SCHEMBL8311361

O=C(c1ccc(Nc2nccc(-c3ccc(Cl)cc3)n2)cc1)N1CCN(C(=O)c2ccc3ccccc3c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 6/20 0.56
▸ CHUK O15111 4/20 0.56
▸ IKBKG Q9Y6K9 3/20 0.56
▸ CAMK2D Q13557 3/20 0.53
▸ MTOR P42345 1/20 0.52
▸ SMG1 Q96Q15 1/20 0.52
▸ PIK3CG P48736 3/20 0.51
▸ PIK3CA P42336 2/20 0.51
▸ PIK3CB P42338 2/20 0.51
▸ MAPK8 P45983 2/20 0.51
▸ MAPK10 P53779 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ BLM P54132 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ PRKCZ Q05513 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ PLK1 P53350 1/20 0.50
▸ GSK3B P49841 2/20 0.49
▸ DKK1 O94907 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14063828 0.91 CAMK2D (0.61) IKBKBCHUKIKBKGCAMK2DMTOR
SCHEMBL14021219 0.87 PIK3CA (0.58) IKBKBCHUKIKBKGCAMK2DMTOR
SCHEMBL14021251 0.86 JAK2 (0.57) IKBKBCHUKIKBKGCAMK2DPIK3CG
SCHEMBL14021222 0.86 PIK3CA (0.53) IKBKBCHUKIKBKGCAMK2DMTOR
SCHEMBL1512786 0.86 PIK3CA (0.55) IKBKBCHUKIKBKGCAMK2DPIK3CG
SCHEMBL8312148 0.86 CDK1 (0.62) IKBKBCHUKCAMK2DPIK3CGPIK3CA
SCHEMBL14021190 0.86 MTOR (0.60) IKBKBCHUKIKBKGCAMK2DMTOR
SCHEMBL11924733 0.86 MTOR (0.60) IKBKBCHUKIKBKGCAMK2DMTOR
SCHEMBL8311767 0.86 SYK (0.56) —
SCHEMBL28954223 0.85 PIK3CA (0.52) IKBKBCHUKIKBKGCAMK2DMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback